Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation

Tissue Engineering - Part A

Volumn 15, Issue 2, 2009, Pages 263-272

  Hsiong, Susan X ^a,b   Boontheekul, Tanyarut ^c   Huebsch, Nathaniel ^b,d   Mooney, David J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HARVARD UNIVERSITY   (United States)

^c INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; AMINES; AMINO ACIDS; BIOCHEMISTRY; BONE; CELL PROLIFERATION; LIGANDS; THREE DIMENSIONAL;

3D CULTURES; ASPARTATE; BONE REGENERATIONS; CELL DIFFERENTIATIONS; DESIGN PARAMETERS; DIFFERENTIATED CELLS; EXTRA CELLULAR MATRICES; HUMAN BONE MARROW STROMAL CELL (HBMSC); INTEGRIN; LIGAND BINDINGS; LIGAND CONFORMATIONS; MATRIXES; MC3T3-E1; MORPHOGENS; OSTEOGENIC DIFFERENTIATIONS; PREOSTEOBLASTS; STEM CELL DIFFERENTIATIONS; STEM CELLS; THREE-DIMENSIONAL (3D); TRANSPLANTED CELLS;

CELL CULTURE;

ARGININEGLYCINEASPARTATE PEPTIDE; INTEGRIN; LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; STEM CELL; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; MICE; MULTIPOTENT STEM CELLS; OSTEOGENESIS; PEPTIDES, CYCLIC; STEM CELLS; STROMAL CELLS; TISSUE CULTURE TECHNIQUES;

EID: 65349153770     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0411     Document Type: Article

References (52)

1. Holland, T.A., and Mikos, A.G. Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. Adv Biochem Eng Biotechnol 102, 161, 2006.
2. Hutmacher, D.W., Schantz, J.T., Lam, C.X., Tan, K.C., and Lim, T.C. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 1, 245, 2007.
3. Betz, V.M., Betz, O.B., Harris, M.B., Vrahas, M.S., and Evans, C.H. Bone tissue engineering and repair by gene therapy. Front Biosci 13, 833, 2008.
4. Stevens, B., Yang, Y., Mohandas, A., Stucker, B., and Nguyen, K.T. A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. J Biomed Mater Res B Appl Biomater 85, 573, 2008.
5. Sokolsky-Papkov, M., Agashi, K., Olaye, A., Shakesheff, K., and Domb, A.J. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 59, 187, 2007.
6. Tsutsumi, S., Shimazu, A., Miyazaki, K., Pan, H., Koike, C., Yoshida, E., Takagishi, K., and Kato, Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288, 413, 2001.
7. Caplan, A.I., and Bruder, S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7, 259, 2001.
8. Clinicaltrials.gov. Results of 2007 ''stem cells'' query in database.
9. Sittinger, M., Hutmacher, D.W., and Risbud, M.V. Current strategies for cell delivery in cartilage and bone regeneration. Curr Opin Biotechnol 15, 411, 2004.
10. Macdonald, K.K., Cheung, C.Y., and Anseth, K.S. Cellular delivery of TGFbeta1 promotes osteoinductive signalling for bone regeneration. J Tissue Eng Regen Med 1, 314, 2007.
11. Torigoe, I., Sotome, S., Tsuchiya, A., Yoshii, T., Takahashi, M., Kawabata, S., and Shinomiya, K. Novel cell seeding system into a porous scaffold using a modified low-pressure method to enhance cell seeding efficiency and bone formation. Cell Transplant 16, 729, 2007.
12. Fox, J.M., Chamberlain, G., Ashton, B.A., and Middleton, J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137, 491, 2007.
13. Saito, N., Okada, T., Horiuchi, H., Murakami, N., Takahashi, J., Nawata, M., Ota, H., Nozaki, K., and Takaoka, K. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 19, 332, 2001.
14. Karageorgiou, V., Meinel, L., Hofmann, S., Malhotra, A., Volloch, V., and Kaplan, D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 71, 528, 2004.
15. Schmoekel, H., Schense, J.C., Weber, F.E., Gratz, K.W., Gnagi, D., Muller, R., and Hubbell, J.A. Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J Orthop Res 22, 376, 2004.
16. Simmons, C.A., Alsberg, E., Hsiong, S., Kim, W.J., and Mooney, D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35, 562, 2004.
17. Alsberg, E., Anderson, K.W., Albeiruti, A., Franceschi, R.T., and Mooney, D.J. Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res 80, 2025, 2001.
18. Lee, K.Y., and Mooney, D.J. Hydrogels for tissue engineering. Chem Rev 101, 1869, 2001.
19. Smidsrod, O., and Skjak-Braek, G. Alginate as immobilization matrix for cells. Trends Biotechnol 8, 71, 1990.
20. Atala, A., Kim, W., Paige, K.T., Vacanti, C.A., and Retik, A.B. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J Urol 152, 641, 1994.
21. Rowley, J.A., Madlambayan, G., and Mooney, D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45, 1999.
22. Shapiro, H.S., Chen, J., Wrana, J.L., Zhang, Q., Blum, M., and Sodek, J. Characterization of porcine bone sialoprotein: primary structure and cellular expression. Matrix 13, 431, 1993.
23. Kumagai, H., Tajima, M., Ueno, Y., Giga-Hama, Y., and Ohba, M. Effect of cyclic RGD peptide on cell adhesion and tumor metastasis. Biochem Biophys Res Commun 177, 74, 1991.
24. Liu, S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol Pharm 3, 472, 2006.
25. Diduch, D.R., Coe, M.R., Joyner, C., Owen, M.E., and Balian, G. Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization. J Bone Joint Surg Am 75, 92, 1993.
26. Li, X., Cui, Q., Kao, C., Wang, G.J., and Balian, G. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33, 652, 2003.
27. Li, X., Jin, L., Cui, Q., Wang, G.J., and Balian, G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16, 101, 2005.
28. Devine, M.J., Mierisch, C.M., Jang, E., Anderson, P.C., and Balian, G. Transplanted bone marrow cells localize to fracture callus in a mouse model. J Orthop Res 20, 1232, 2002.
29. Yanai, T., Katagiri, T., Akiyama, S., Imada, M., Yamashita, T., Chiba, H., Takahashi, N., and Suda, T. Expression of mouse osteocalcin transcripts, OG1 and OG2, is differently regulated in bone tissues and osteoblast cultures. J Bone Miner Metab 19, 345, 2001.
30. Guo, J.F., Jourdian, G.W., and MacCallum, D.K. Culture and growth characteristics of chondrocytes encapsulated in al-ginate beads. Connect Tissue Res 19, 277, 1989.
31. Lowry, O.H., Roberts, N.R., Wu, M.L., Hixon, W.S., and Crawford, E.J. The quantitative histochemistry of brain. II. Enzyme measurements. J Biol Chem 207, 19, 1954.
32. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
33. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64, 295, 1997.
34. Cheng, S.L., Yang, J.W., Rifas, L., Zhang, S.F., and Avioli, L.V. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134, 277, 1994.
35. Asahina, I., Sampath, T.K., and Hauschka, P.V. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/ or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222, 38, 1996.
36. Carpenter, T.O., Moltz, K.C., Ellis, B., Andreoli, M., McCarthy, T.L., Centrella, M., Bryan, D., and Gundberg, C.M. Osteocalcin production in primary osteoblast cultures derived from normal and Hyp mice. Endocrinology 139, 35, 1998.
37. Kantlehner, M., Schaffner, P., Finsinger, D., Meyer, J., Jonczyk, A., Diefenbach, B., Nies, B., Holzemann, G., Goodman, S.L., and Kessler, H. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 1, 107, 2000.
38. Lieb, E., Hacker, M., Tessmar, J., Kunz-Schughart, L.A., Fiedler, J., Dahmen, C., Hersel, U., Kessler, H., Schulz, M.B., and Gopferich, A. Mediating specific cell adhesion to lowadhesive diblock copolymers by instant modification with cyclic RGD peptides. Biomaterials 26, 2333, 2005.
39. Krebsbach, P.H., Kuznetsov, S.A., Bianco, P., and Robey, P.G. Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 10, 165, 1999.
40. Xiao, G., Cui, Y., Ducy, P., Karsenty, G., and Franceschi, R.T. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endocrinol 11, 1103, 1997.
41. Luppen, C.A., Smith, E., Spevak, L., Boskey, A.L., and Frenkel, B. Bone morphogenetic protein-2 restores mineral- ization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res 18, 1186, 2003.
42. Lian, J.B., Shalhoub, V., Aslam, F., Frenkel, B., Green, J., Hamrah, M., Stein, G.S., and Stein, J.L. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 138, 2117, 1997.
43. Pfaff, M., Tangemann, K., Muller, B., Gurrath, M., Muller, G., Kessler, H., Timpl, R., and Engel, J. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem 269, 20233, 1994.
44. Pierschbacher, M.D., and Ruoslahti, E. Variants of the cell recognition site of fibronectin that retain attachmentpromoting activity. Proc Natl Acad Sci U S A 81, 5985, 1984.
45. Kong, H.J., Boontheekul, T., and Mooney, D.J. Quantifying the relation between adhesion ligand-receptor bond formation and cell phenotype. Proc Natl Acad Sci U S A 103, 18534, 2006.
46. Schneider, G.B., Zaharias, R., and Stanford, C. Osteoblast integrin adhesion and signaling regulate mineralization. J Dent Res 80, 1540, 2001.
47. Bogdanowich-Knipp, S.J., Chakrabarti, S., Williams, T.D., Dillman, R.K., and Siahaan, T.J. Solution stability of linear vs. cyclic RGD peptides. J Pept Res 53, 530, 1999.
48. Salasznyk, R.M., Klees, R.F., Williams, W.A., Boskey, A., and Plopper, G.E. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res 313, 22, 2007.
49. Aota, S., Nomizu, M., and Yamada, K.M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 269, 24756, 1994.
50. Pistone, M., Sanguineti, C., Federici, A., Sanguineti, F., Defilippi, P., Santolini, F., Querze, G., Marchisio, P.C., and Manduca, P. Integrin synthesis and utilization in cultured human osteoblasts. Cell Biol Int 20, 471, 1996.
51. Bennett, J.H., Carter, D.H., Alavi, A.L., Beresford, J.N., and Walsh, S. Patterns of integrin expression in a human mandibular explant model of osteoblast differentiation. Arch Oral Biol 46, 229, 2001.
52. Petrie, T.A., Capadona, J.R., Reyes, C.D., and Garcia, A.J. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. Biomaterials 27, 5459, 2006.